All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis
Volume: 18, Issue: 1, Pages: 51 - 53
Published: Jan 1, 2020
Abstract
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease highly associated with inflammatory bowel disease (IBD). PSC is characterized by inflammation of the intrahepatic and extrahepatic bile ducts, leading to destruction of the biliary epithelium, periductular fibrosis, and eventually end-stage liver disease. PSC is also associated to a significant risk of cholangiocarcinoma and gall bladder carcinoma.1Eksteen B. The...
Paper Details
Title
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis
Published Date
Jan 1, 2020
Volume
18
Issue
1
Pages
51 - 53
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History